Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE: 532523, NSE: ...
Bengaluru: Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd, has announced that Health Canada has granted a Notice of ...
The approval of Yesintek and Yesintek I.V., biosimilars to Stelara, strengthens Biocon Biologics' presence in North America and expands its immunology portfolio ...
Rani Therapeutics secured a $1.085 billion collaboration with Chugai Pharmaceutical. Check out why I am initiating with a Buy ...
Biocon said that Health Canada has granted a notice of compliance (NOC) for Yesintek and Yesintek I.V. to Biocon Biologics.
Oral and inhaled biologics are gaining R&D investment due to patient acceptance and potential for home administration, with ...
Biocon Biologics gets Health Canada nod for Yesintek and Yesintek IV, a biosimilar to Stelara: Our Bureau, Bengaluru Thursday, October 23, 2025, 14:30 Hrs [IST] Biocon Biologics L ...
In the short term, Eli Lilly and Novo Nordisk will continue to dominate due to strong branding and doctor trust. But in the ...
Halozyme acquires Elektrofi to expand drug delivery with high-concentration biologics. Discover how this boosts growth and ...
MedPage Today on MSN
Adverse Event Risks Vary Among Asthma Biologics, FDA Data Show
CHICAGO -- Adverse event risks varied across biologics used by asthma patients, an analysis of data submitted to the FDA ...
Biocon Biologics has made strides in the healthcare sector by obtaining Health Canada’s approval for Yesintek and Yesintek IV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback